A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
Clinical trial NCT00082212 · TERMINATED
Trial details
- NCT number
- NCT00082212
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.